Human Growth Hormone Market Size, Key Players, Latest Insights, Trends, Opportunity and Forecast to 2027

According to IMARC Group's latest report, titled "𝗛𝘂𝗺𝗮𝗻 𝗚𝗿𝗼𝘄𝘁𝗵 𝗛𝗼𝗿𝗺𝗼𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳", The market to reach US$ 7.9 Billion by 2027, exhibiting a CAGR of 8.47% during 2022-2027.

Human growth hormone, also known as HGH, refers to a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. It generally regulates the regeneration, repair, reproduction, and metabolism of the cells, thereby contributing to the overall development of the body. Human growth hormone also manages body fluids, fat metabolism, bone and muscle growth, etc. The deficiency of HGH can increase the risk of chronic diseases and fat accumulation, whereas higher levels can cause gigantism and acromegaly, muscle-wasting disease, short bowel syndrome in adults, etc.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗯𝗿𝗼𝗰𝗵𝘂𝗿𝗲: https://www.imarcgroup.com/human-growth-hormone-market/requestsample

𝗛𝘂𝗺𝗮𝗻 𝗚𝗿𝗼𝘄𝘁𝗵 𝗛𝗼𝗿𝗺𝗼𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀:

The growing prevalence of Turner syndrome, which is a chromosomal disorder distinguished by complete or partial loss of X chromosomes, is among the key factors stimulating the human growth hormone market. Moreover, growth hormones are usually administered to reverse some of the symptoms of this disease, thereby escalating the demand for HGH drugs across countries. Besides this, the increasing consumer health consciousness, the development of recombinant human growth hormone (rHGH), and the inflating need for preventive measures against endocrine disorders are positively influencing the global market. Furthermore, the rising occurrence of disorders, including Prader-Willi syndrome (PWS) and idiopathic short stature (ISS) that are caused by the deficiency of growth hormones in the body and can be treated by using medically synthesized medications, is acting as another significant growth-inducing factor. Apart from this, the widespread adoption of HGH as performance enhancers by bodybuilders is anticipated to fuel the human growth hormone market over the forecasted period.

𝗖𝗵𝗲𝗰𝗸𝗼𝘂𝘁 𝗡𝗼𝘄: https://www.imarcgroup.com/checkout?id=2052&method=1

𝗛𝘂𝗺𝗮𝗻 𝗚𝗿𝗼𝘄𝘁𝗵 𝗛𝗼𝗿𝗺𝗼𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗪𝗶𝘁𝗵 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀:

The competitive landscape of the human growth hormone market has been studied in the report with the detailed profiles of the key players operating in the market.

𝗦𝗼𝗺𝗲 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

• Eli Lilly and Company
• EMD Serono Inc.
• F. Hoffmann-La Roche AG
• Ferring B.V.
• Genentech Inc.
• Ipsen
• Merck KGaA
• Novartis AG
• Novo Nordisk
• Pfizer Inc.
• Sandoz, etc.

𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗪𝗶𝘁𝗵 𝗧𝗢𝗖 & 𝗟𝗶𝘀𝘁 𝗼𝗳 𝗙𝗶𝗴𝘂𝗿𝗲𝘀: https://www.imarcgroup.com/human-growth-hormone-market/toc

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

The report has segmented the global human growth hormone market on the basis of application, distribution channel, route of administration and region.

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻:

• Growth Hormone (GH) Deficiency
o Adult GH Deficiency
o Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature (ISS)
• Prader-Willi Syndrome (PWS)
• Small for Gestational Age
• Others

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗗𝗶𝘀𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻 𝗖𝗵𝗮𝗻𝗻𝗲𝗹:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗥𝗼𝘂𝘁𝗲 𝗼𝗳 𝗔𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻:

• Intravenous
• Intramuscular
• Subcutaneous
• Oral

𝗕𝗿𝗲𝗮𝗸𝘂𝗽 𝗯𝘆 𝗥𝗲𝗴𝗶𝗼𝗻:

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

𝗔𝘀𝗸 𝗔𝗻𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝟭𝟬% 𝗳𝗿𝗲𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/request?type=report&id=2052&flag=C

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

𝗠𝗲𝗱𝗶𝗮 𝗖𝗼𝗻𝘁𝗮𝗰𝘁:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com/

This release was published on openPR.